NSC |
Compound |
Enrichment |
Correlation |
NSC 732830 |
N1-(4-fluorophenyl)-4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihyd ro-1H-3-pyrrolylamino)benzamide |
0.0178844438004194 |
0.29297647 |
NSC 742860 |
Null |
0.0178844438004194 |
0.42360923 |
NSC 743434 |
8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one |
0.0178844438004194 |
0.46981202 |
NSC 752464 |
methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate |
0.0178844438004194 |
0.43204923 |
NSC 112846 |
N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid |
0.0178844438004195 |
0.5100677 |
NSC 127328 |
Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- |
0.0178844438004195 |
0.045422754 |
NSC 128687 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) |
0.0178844438004195 |
0.51334027 |
NSC 215721 |
Null |
0.0178844438004195 |
0.15686443 |
NSC 335789 |
3-Azabicyclo[3.2.1]nonane-3-carbothioic acid, [1-(6-methyl-2-pyridinyl)ethylidene]hydrazide |
0.0178844438004195 |
0.48931706 |
NSC 348977 |
1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide, dihydrochloride |
0.0178844438004195 |
0.32052854 |